These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 32100675)
1. ELISA Saliva for de Oliveira LC; Pereira NB; Moreira CHV; Bierrenbach AL; Salles FC; de Souza-Basqueira M; Manuli ER; Ferreira AM; Oliveira CDL; Cardoso CS; Ribeiro ALP; Sabino EC Am J Trop Med Hyg; 2020 Apr; 102(4):800-803. PubMed ID: 32100675 [TBL] [Abstract][Full Text] [Related]
2. Saliva ELISA: a method for the diagnosis of chronic Chagas disease in endemic areas. Pinho RT; Pedrosa RC; Costa-Martins P; Castello-Branco LR Acta Trop; 1999 Jan; 72(1):31-8. PubMed ID: 9924959 [TBL] [Abstract][Full Text] [Related]
3. Anti-Trypanosoma cruzi antibody detection in eastern Andalusia (Spain). Marín C; Concha-Valdez F; Cañas R; Gutiérrez-Sánchez R; Sánchez-Moreno M Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):165-72. PubMed ID: 24463719 [TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil. Rosenthal LD; Petrarca CR; Mesenburg MA; Villela MM Rev Soc Bras Med Trop; 2016; 49(6):768-771. PubMed ID: 28001226 [TBL] [Abstract][Full Text] [Related]
5. Chagas Disease Control Programme in Brazil: a study of the effectiveness of 13 years of intervention. Costa FC; Vitor RW; Antunes CM; Carneiro M Bull World Health Organ; 1998; 76(4):385-91. PubMed ID: 9803589 [TBL] [Abstract][Full Text] [Related]
6. Clinical and epidemiological characteristics of Chagas disease in an endemic area of Sergipe State, Brazil. Glass IR; Santos ADD; Varjão AEL; Costa IS; Correia D; Silva ÂM Rev Soc Bras Med Trop; 2018; 51(5):660-664. PubMed ID: 30304273 [TBL] [Abstract][Full Text] [Related]
8. Serological evaluation for Chagas disease in migrants from Latin American countries resident in Rome, Italy. Pane S; Giancola ML; Piselli P; Corpolongo A; Repetto E; Bellagamba R; Cimaglia C; Carrara S; Ghirga P; Oliva A; Bevilacqua N; Al Rousan A; Nisii C; Ippolito G; Nicastri E BMC Infect Dis; 2018 May; 18(1):212. PubMed ID: 29739357 [TBL] [Abstract][Full Text] [Related]
9. A simple Trypanosoma cruzi enzyme-linked immunoassay for control of human infection in nonendemic areas. Aznar C; Liegeard P; Mariette C; Lafon S; Levin MJ; Hontebeyrie M FEMS Immunol Med Microbiol; 1997 May; 18(1):31-7. PubMed ID: 9215584 [TBL] [Abstract][Full Text] [Related]
10. Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic. Guzmán-Gómez D; López-Monteon A; de la Soledad Lagunes-Castro M; Álvarez-Martínez C; Hernández-Lutzon MJ; Dumonteil E; Ramos-Ligonio A Parasit Vectors; 2015 Sep; 8():466. PubMed ID: 26384317 [TBL] [Abstract][Full Text] [Related]
11. Do commercial serologic tests for Trypanosoma cruzi infection detect Mexican strains in women and newborns? Gamboa-León R; Gonzalez-Ramirez C; Padilla-Raygoza N; Sosa-Estani S; Caamal-Kantun A; Buekens P; Dumonteil E J Parasitol; 2011 Apr; 97(2):338-43. PubMed ID: 21506787 [TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides. Ferreira AW; Belem ZR; Lemos EA; Reed SG; Campos-Neto A J Clin Microbiol; 2001 Dec; 39(12):4390-5. PubMed ID: 11724850 [TBL] [Abstract][Full Text] [Related]
13. The sero-prevalence of antibodies to trypanosoma cruzi in Latin American refugees and immigrants to Canada. Steele LS; MacPherson DW; Kim J; Keystone JS; Gushulak BD J Immigr Minor Health; 2007 Jan; 9(1):43-7. PubMed ID: 17006766 [TBL] [Abstract][Full Text] [Related]
14. Systematic neonatal screening for congenital Chagas disease in Northeast Brazil: prevalence of Trypanosoma cruzi infection in the Southern region of Sergipe. Santos FRD; Euzébio DM; Oliveira GG; Chagas MS; Ferreira AR; Mendonça LA; Correia D; Silva AMD Rev Soc Bras Med Trop; 2018; 51(3):310-317. PubMed ID: 29972561 [TBL] [Abstract][Full Text] [Related]
15. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens. Umezawa ES; Bastos SF; Coura JR; Levin MJ; Gonzalez A; Rangel-Aldao R; Zingales B; Luquetti AO; da Silveira JF Transfusion; 2003 Jan; 43(1):91-7. PubMed ID: 12519436 [TBL] [Abstract][Full Text] [Related]
16. Lack of evidence of seronegative infection in an endemic area of Chagas disease. Oliveira LC; Lee TH; Ferreira AM; Bierrenbach AL; Souza-Basqueira M; Oliveira CDL; Cardoso CS; Moreira CHV; Oikawa MK; Ribeiro ALP; Busch MP; Sabino EC Rev Inst Med Trop Sao Paulo; 2019 Feb; 61():e11. PubMed ID: 30785565 [TBL] [Abstract][Full Text] [Related]
17. Combined use of enzyme-linked immunosorbent assay and flow cytometry to detect antibodies to Trypanosoma cruzi in domestic canines in Texas. Shadomy SV; Waring SC; Martins-Filho OA; Oliveira RC; Chappell CL Clin Diagn Lab Immunol; 2004 Mar; 11(2):313-9. PubMed ID: 15013981 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of Trypanosoma cruzi infection among Bolivian immigrants in the city of São Paulo, Brazil. Luna EJ; Furucho CR; Silva RA; Wanderley DM; Carvalho NB; Satolo CG; Leite RM; Silveira C; Silva LM; Aith FM; Carneiro N; Shikanai-Yasuda MA Mem Inst Oswaldo Cruz; 2017 Jan; 112(1):70-74. PubMed ID: 27849221 [TBL] [Abstract][Full Text] [Related]